Fmoc-D-Dab(Mtt)-OH

Fmoc-D-Dab(Mtt)-OH is an Fmoc-protected D-configured amino acid derivative featuring an N-fluorenylmethoxycarbonyl (Fmoc) group on the amino nitrogen and a D-2,3-diaminobutyric acid-like side-chain architecture terminated by an Mtt-protected amine (Mtt = 4-methyltrityl). The molecule presents a stereogenic center at the D-amino acid backbone, a free carboxylic acid for peptide coupling, and a bulky acid-labile Mtt protecting group that can be selectively removed under conditions compatible with many peptide synthesis workflows. The presence of orthogonally protected amines supports controlled sequential functionalization, enabling selective deprotection of the side-chain while maintaining the Fmoc group for iterative solid-phase or solution-phase assembly. The overall reactivity profile is governed by the protected amines and the carboxylic acid, making the compound a chiral, protected amino acid building block suited for downstream peptide construction and side-chain elaboration.

1. Peptide Synthesis

Fmoc-D-Dab(Mtt)-OH is applied in peptide synthesis as a chiral, orthogonally protected amino acid building block for introducing D-configured Dab residues into peptide chains. The free carboxylic acid participates in standard peptide coupling chemistry, while the Fmoc group enables N-terminal protection during stepwise assembly and subsequent deprotection for chain elongation. The Mtt-protected side-chain amine remains masked through coupling steps, supporting chemoselective side-chain unmasking at a chosen stage to generate a defined cationic or nucleophilic handle. Incorporation of the D-stereocenter can be used to modulate backbone conformation and proteolytic stability in peptide analogs, and the orthogonal protecting-group pattern supports controlled peptide scaffold generation for research-grade structure refinement.

2. Side-Chain Functionalization

Fmoc-D-Dab(Mtt)-OH is used for side-chain functionalization strategies that require selective exposure of an amine after peptide or fragment assembly. The Mtt group provides a sterically demanding, acid-labile protection mode for the side-chain nitrogen, enabling timed deprotection to yield a reactive primary amine without disturbing the Fmoc-protected backbone during earlier stages. The resulting free amine can be employed for subsequent derivatization such as acylation, sulfonylation, reductive amination, or coupling to activated electrophiles, allowing installation of functional motifs for molecular recognition studies. The D-configured backbone also supports stereochemically defined analogs, which can be leveraged in amino acid derivatization workflows where side-chain chemistry and stereochemical control are coupled.

3. Chemical Biology Probes

Fmoc-D-Dab(Mtt)-OH is suitable for chemical biology applications where protected amino acid chemistry enables the construction of labeled or reactive peptide probes. The orthogonal protection pattern supports incorporation into peptide sequences while preserving a masked side-chain amine that can later be revealed for conjugation to dyes, affinity tags, or capture handles. The Fmoc-protected N-terminus supports controlled peptide assembly, and the D-stereochemistry can be used to tune probe stability and binding conformations in biochemical assays without relying on unprotected amines during synthesis. Downstream, the exposed side-chain amine can serve as a functional anchor for generating bioconjugatable intermediates that integrate into peptide-based molecular tools.

4. Peptidomimetic Construction

Fmoc-D-Dab(Mtt)-OH is applied in peptidomimetic construction and SAR-oriented scaffold design as a protected chiral residue that can introduce conformational and charge features into non-natural peptide frameworks. The D-configured amino acid backbone, combined with an orthogonally protected side-chain amine, allows stepwise synthesis of analogs where the side-chain can be unmasked and further elaborated to match binding pocket requirements. The carboxylic acid functionality supports incorporation into peptide-like chains, while the Mtt group enables late-stage functional group installation to generate libraries of peptidomimetic variants. The resulting intermediates can be carried into downstream synthetic steps for fragment elaboration, receptor-binding studies, and structure-activity relationship investigations within medicinal chemistry programs.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Dab(Mtt)-OH is relevant to pharmaceutical intermediate preparation in fine chemical manufacturing contexts where orthogonally protected amino acids are used to control chemoselectivity during synthesis of peptide-derived active ingredients or advanced intermediates. The Fmoc group supports reproducible protection of the amino functionality during multistep assembly, while the Mtt-protected side-chain amine provides a controlled deprotection handle for introducing reactive functionality at a specified stage of the manufacturing sequence. The presence of a single carboxylic acid enables coupling-compatible handling as a defined building block for generating larger protected fragments that can be carried through purification and subsequent transformation steps. The stereochemical integrity of the D-amino acid and the protected functional-group pattern support consistent intermediate generation for downstream peptide coupling, conjugation, and final deprotection operations in industrial peptide chemistry.

6. Process Chemistry Intermediate

Fmoc-D-Dab(Mtt)-OH serves as a process chemistry intermediate for developing scalable routes to protected amino acid derivatives and peptide fragments. The orthogonal Fmoc/Mtt protection strategy enables separation of protection and functionalization events, supporting manufacturing workflows that require predictable timing of deprotection and minimal side reactions from free amines. The compound's chiral backbone and protected amine functionality can be employed to design robust intermediate sequences for producing defined stereochemical motifs in larger molecules. Downstream utility includes conversion into activated coupling forms for fragment assembly and transformation of the revealed side-chain amine into processable derivatives used in fine chemical synthesis and peptide-based intermediate manufacturing.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling